{
  "id": 4733,
  "text": "Int J Gynecol Cancer, 2020, 30(8):1097‑1100.DOI: 10.1136/ijgc‑2020‑001617.[12] Perkins RB, Guido RS, Castle PE, et al.2019 ASCCP Risk‑Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors[J].",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Int J Gynecol Cancer, 2020, 30(8):1097‑1100.DOI: 10.1136/ijgc‑2020‑001617.[12] Perkins RB, Guido RS, Castle PE, et al.2019 ASCCP Risk‑Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors[J].\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "宫颈癌筛查异常结果的风险管理共识指南为临床决策提供了基于风险的框架，有助于优化患者的管理策略。这一指南重视评估患者在未来5年内发展为宫颈上皮内瘤样病变（CIN3+）或子宫颈癌的风险，通过具体的风险阈值，指导进一步检查或治疗的选择。例如，对于高风险患者，建议立即进行诊断性活检；而对于低风险患者，可选择密切随访而非干预，从而减少不必要的治疗。\n\n此外，新指南倡导动态管理，即根据患者既往筛查结果、治疗史以及当前的筛查结果综合评估风险。这种方法使得临床医师能够精准地提供个体化干预，避免过度治疗或治疗不足，同时提高患者的依从性并减少医疗资源浪费。\n\n因此，该指南不仅规范了临床流程，也显著提升了宫颈癌筛查工作的效率和安全性，为宫颈癌的一级和二级预防提供了重要依据。",
  "query": "宫颈癌筛查异常结果的风险管理共识指南是如何影响临床决策的？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 宫颈癌筛查异常结果的风险管理共识指南是如何影响临床决策的？\n\n<reference text>: Int J Gynecol Cancer, 2020, 30(8):1097‑1100.DOI: 10.1136/ijgc‑2020‑001617.[12] Perkins RB, Guido RS, Castle PE, et al.2019 ASCCP Risk‑Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors[J].\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "宫颈癌筛查异常结果的风险管理共识指南为临床决策提供了基于风险的框架，有助于优化患者的管理策略。这一指南重视评估患者在未来5年内发展为宫颈上皮内瘤样病变（CIN3+）或子宫颈癌的风险，通过具体的风险阈值，指导进一步检查或治疗的选择。例如，对于高风险患者，建议立即进行诊断性活检；而对于低风险患者，可选择密切随访而非干预，从而减少不必要的治疗。\n\n此外，新指南倡导动态管理，即根据患者既往筛查结果、治疗史以及当前的筛查结果综合评估风险。这种方法使得临床医师能够精准地提供个体化干预，避免过度治疗或治疗不足，同时提高患者的依从性并减少医疗资源浪费。\n\n因此，该指南不仅规范了临床流程，也显著提升了宫颈癌筛查工作的效率和安全性，为宫颈癌的一级和二级预防提供了重要依据。"
}